We are live on
!
Find out more
JBIO
Jade Biosciences
JBIO
JBIO
68 hedge funds and large institutions have $803M invested in Jade Biosciences in 2022 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 16 increasing their positions, 22 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
130% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 10
85% more capital invested
Capital invested by funds: $434M → $803M (+$369M)
24% more funds holding
Funds holding: 55 → 68 (+13)
14% more funds holding in top 10
Funds holding in top 10: 7 → 8 (+1)
0.03% more ownership
Funds ownership: 3.15% → 3.18% (+0.03%)
27% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 22
Holders
68
Holders Change
+13
Holders Change %
+23.64%
% of All Funds
1.09%
Holding in Top 10
8
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+14.29%
% of All Funds
0.13%
New
23
Increased
16
Reduced
22
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$7.75M |
| 2 |
AVLSA
Atlas Venture Life Science Advisors
Cambridge,
Massachusetts
|
-$6.44M |
| 3 |
LCM
Lynx1 Capital Management
San Juan,
Puerto Rico
|
-$4.58M |
| 4 |
BlackRock
New York
|
-$2.23M |
| 5 |
VA
VR Adviser
New York
|
-$1.78M |
